Which are the causes of Trimethylaminuria?

Trimethylaminuria is a metabolic disorder primarily caused by a deficiency in the enzyme flavin-containing monooxygenase 3 (FMO3), which prevents the body from breaking down trimethylamine, a compound with a strong fishy odor. This condition is usually hereditary, resulting from specific genetic mutations, though it can also be influenced by transient environmental and dietary factors.

What causes Trimethylaminuria at a biological level?

In a healthy system, the liver produces the FMO3 enzyme, which acts like a biological "filter" to convert foul-smelling trimethylamine into odorless trimethylamine N-oxide. In individuals with Trimethylaminuria, this enzyme is either missing or functions poorly. Because the body cannot process the trimethylamine, it accumulates and is released through sweat, urine, and breath. Think of it like a clogged drain; when the FMO3 "filter" is blocked, the byproduct overflows into the body’s excretory systems.

Is Trimethylaminuria a hereditary condition?

Trimethylaminuria is most commonly inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of a mutated FMO3 gene—one from each parent—to manifest the condition. However, the genetic landscape of Trimethylaminuria is complex; some carriers of only one mutation may experience mild, intermittent symptoms. Researchers have identified over 40 different mutations in the FMO3 gene that contribute to varying degrees of enzyme dysfunction.

What are the environmental and secondary triggers?

While genetics are the primary cause, secondary factors can exacerbate Trimethylaminuria or trigger symptoms in individuals with reduced enzyme activity:

• Dietary intake: Consuming foods high in choline, carnitine, or lecithin (such as eggs, liver, legumes, and saltwater fish) increases trimethylamine production.


• Hormonal fluctuations: Many patients report that symptoms worsen during puberty or menstruation due to hormonal shifts.


• Gut microbiome: An imbalance of gut bacteria can increase the production of trimethylamine before it even reaches the liver.


• Liver or kidney impairment: Reduced organ function can further diminish the body’s ability to process these compounds.

How is research advancing our understanding of the etiology?

Current research into Trimethylaminuria is focused on identifying the full spectrum of FMO3 mutations and developing targeted therapies to modulate gut bacteria. Scientists are also investigating why some individuals with identical genetic profiles exhibit vastly different symptom severity, suggesting that epigenetic factors and the gut microbiome play larger roles in Trimethylaminuria than previously understood.

Next steps

• Consult a metabolic specialist or geneticist to discuss FMO3 genetic testing.


• Request a referral to a dietitian experienced in managing metabolic disorders to track choline intake.


• Join the 34 members of the DiseaseMaps.org community to share experiences and coping strategies.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Trimethylaminuria


• Orphanet: Trimethylaminuria (ORPHA:93575)


• OMIM (Online Mendelian Inheritance in Man): FMO3 Gene (Entry 136132)


• National Center for Biotechnology Information (NCBI) GeneReviews: Trimethylaminuria